603676 卫信康
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)15.05418.06216.71415.4699.355
总资产报酬率 ROA (%)11.64913.56112.43411.1966.717
投入资产回报率 ROIC (%)14.56317.48416.19215.1449.258

边际利润分析
销售毛利率 (%)61.85554.24450.81552.60251.588
营业利润率 (%)31.86821.60013.22811.6279.896
息税前利润/营业总收入 (%)30.96921.06115.99012.82111.060
净利润/营业总收入 (%)25.41418.93316.18112.6539.279

收益指标分析
经营活动净收益/利润总额(%)76.00883.62567.52391.57881.929
价值变动净收益/利润总额(%)13.6757.35211.3138.6409.914
营业外收支净额/利润总额(%)-2.477-1.53818.93810.83210.456

偿债能力分析
流动比率 (X)4.0693.0793.0392.7662.407
速动比率 (X)3.9272.9812.9422.6872.353
资产负债率 (%)20.05625.26024.56826.71028.638
带息债务/全部投入资本 (%)0.0430.2150.3040.2860.325
股东权益/带息债务 (%)226,243.81245,013.63331,837.47233,929.86730,373.846
股东权益/负债合计 (%)398.605295.881307.033274.389249.183
利息保障倍数 (X)-240.000-99.278-48.724-58.8861,291.491

营运能力分析
应收账款周转天数 (天)51.81048.57154.17552.96773.330
存货周转天数 (天)36.36624.29619.61314.99415.956